Technical Analysis for MIR - Medmira Inc

Grade Last Price % Change Price Change
D 0.085 -5.56% -0.005
MIR closed down 5.56 percent on Tuesday, May 28, 2024, on 17 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -5.56%
Bullish Engulfing Bullish -5.56%
Crossed Above 20 DMA Bullish -5.56%
Crossed Above 50 DMA Bullish -5.56%
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low about 20 hours ago
Down 5% about 20 hours ago
Down 3% about 20 hours ago
Down 2% about 20 hours ago
Down 1% about 20 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Medmira Inc Description

MedMira Inc. is a biotechnology company. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company operates through the rapid diagnostic products and services segment. The Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its research focuses on specific areas of the diagnostics market, such as rapid, point-of-care and in vitro sectors. The RVF technology platform includes a three component system: a test cartridge, multi-function buffer and InstantGold Cap. Its technology can be applied in healthcare, research and industrial markets. It offers rapid tests for testing serum, plasma or whole blood specimens. The Company's tests are sold under brands, including Reveal, Multiplo and Miriad. The Company offers rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Gold Health Manufacturing Healthcare Flow Biotechnology Hiv Plasma Diagnostic Products

Is MIR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.135
52 Week Low 0.07
Average Volume 59,383
200-Day Moving Average 0.092
50-Day Moving Average 0.087
20-Day Moving Average 0.089
10-Day Moving Average 0.091
Average True Range 0.006
RSI (14) 45.65
ADX 14.16
+DI 19.636
-DI 27.568
Chandelier Exit (Long, 3 ATRs) 0.083
Chandelier Exit (Short, 3 ATRs) 0.092
Upper Bollinger Bands 0.098
Lower Bollinger Band 0.080
Percent B (%b) 0.26
BandWidth 20.381
MACD Line 0.001
MACD Signal Line 0.001
MACD Histogram -0.0004
Fundamentals Value
Market Cap 55.96 Million
Num Shares 658 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio -28.33
Price-to-Sales 488.86
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.085
Resistance 3 (R3) 0.085 0.085 0.085
Resistance 2 (R2) 0.085 0.085 0.085 0.085
Resistance 1 (R1) 0.085 0.085 0.085 0.085 0.085
Pivot Point 0.085 0.085 0.085 0.085 0.085
Support 1 (S1) 0.085 0.085 0.085 0.085 0.085
Support 2 (S2) 0.085 0.085 0.085 0.085
Support 3 (S3) 0.085 0.085 0.085
Support 4 (S4) 0.085